Infusion criteria | Patients planning pancreaticoduodenectomy
/Age between 18-75
/The heart and lung functions were basically sound without obvious organic diseases
/Good compliance
/Agree and sign the informed consent form for the operation
|
Exclusion criteria | Imaging clearly showed that the tumor invaded the superior mesenteric artery or the superior mesenteric vein more than 180 °
/Preoperative imaging suggested distant metastasis
|
Enrollment | Excluded
|
Date | 2022-2-8 |
Age |
|
Sex | |
BMI index | kg/㎡ |
Smoking | |
Alcohol Consumption | |
Diabetes or not | |
Total protein | g/L |
Albumin | g/L |
Total bilirubin | μmol/L |
prothrombin time | s |
Hemoglobin content | g/L |
Reducing jaundice or not before operation |
Position of the tumor |
|
Diameter of main pancreatic duct | mm |
Operation time | min |
Intraoperative blood loss | ml |
Pancreatic texture | |
Pancreticojejunostomy time | min |
Blood transfusion volume | u |
Converted to open pancreaticoduodenectomy |
Classificaiton of POPF | |
Drainage tube removal time | d |
Pathological type |
|
Postoperative bleeding or not | |
Nasogastric decompression time | d |
Gastric emptying disorder or not | |
Pulmonary infection or not | |
Abdominal infection or not | |
Biliary leakage | |
Reoperation or not | |
Postoperative hospital stay | d |
Hospitalization expenses | yuan |
Postoperative mortality | |
90-Day readmission |